{"id":"NCT00703781","sponsor":"Bausch & Lomb Incorporated","briefTitle":"Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery","officialTitle":null,"status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-06","primaryCompletion":"2008-11","completion":null,"firstPosted":"2008-06-24","resultsPosted":"2011-12-09","lastUpdate":"2015-03-24"},"enrollment":126,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Cataract"],"interventions":[{"type":"DRUG","name":"bromfenac ophthalmic solution","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"Bromfenac","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery","primaryOutcome":{"measure":"Number of Participants With Summed Ocular Inflammation Score (SOIS) of Zero","timeFrame":"Day 15","effectByArm":[{"arm":"Bromfenac","deltaMin":28,"sd":null},{"arm":"Placebo","deltaMin":20,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":61},"commonTop":["Photophobia","Eye Inflammation","Foreign Body Sensation","Eye Pain","Lacrimation Increased"]}}